Showing 8411-8420 of 8647 results for "".
- Roche’s Genentech Unit to Cut 223 Jobs in UShttps://modernod.com/news/roches-genentech-unit-to-cut-223-jobs-in-us/2479930/Roche’s Genentech unit plans to cut 223 jobs from its South San Francisco, California headquarters by the end of the year. The company, which disclosed the staff reductions in a Worker Adjustment and Retraining Notification (WARN) posted by the State of California’s Employment Develop
- T-Cell Immune Responses Drive Neurodegeneration in Glaucomahttps://modernod.com/news/t-cell-immune-responses-drive-neurodegeneration-in-glaucoma/2479933/T-cell immune responses are partly responsible for progressive neurodegeneration in glaucoma, researchers report. “Current treatment of glaucoma is almost all focused on reducing intraocular pressure (IOP) and amelioration of
- Mount Sinai Researchers Discover How to Restore Vision Using Retinal Stem Cellshttps://modernod.com/news/mount-sinai-researchers-discover-how-to-restore-vision-using-retinal-stem-cells/2479939/Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases
- Glasses May Boost Productivity for Rural Workershttps://modernod.com/news/glasses-may-boost-productivity-for-rural-workers/2479941/Providing reading glasses may be an inexpensive way to improve productivity, as well as earnings and quality of life, among workers in developing countries, suggests a clinical trial involving tea pickers in India, according to a Reuters Health
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology for 17th Timehttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology-for-17th-time/2479945/U.S News & World Report has once again ranked Bascom Palmer Eye Institute of the University of Miami Health System as the nation’s best in ophthalmology. Recognized as a global leader in vision research, medical education and patient care, Basco
- ProtoKinetix Enters 3rd Phase of Retinal Cell Replacement Therapy Testing at UBChttps://modernod.com/news/protokinetix-enters-3rd-phase-of-retinal-cell-replacement-therapy-testing-at-ubc/2479948/ProtoKinetix has entered into the third phase of testing in retinal cell replacement therapy at the University of British Columbia. Due to the positive results from the first two phases of testing where the AAGP-treated cells showed a dramatic increase in survivability versus untreated cells over
- Web Vision Technologies Receives Grants to Develop Vision Testing Devices for NASAhttps://modernod.com/news/web-vision-technologies-receives-grants-to-develop-vision-testing-devices-for-nasa/2479953/Web Vision Technologies was recently awarded two grants from Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine to develop vision-testing devices for the National Aeronautical Space Administration (NASA) to be used on the International Space Station (ISS). The
- REGENXBIO Reports Second Quarter 2018 Financial and Operating Results and Interim Data From Ongoing Clinical Trialshttps://modernod.com/news/regenxbio-reports-second-quarter-2018-financial-and-operating-results-and-interim-data-from-ongoing-clinical-trials/2479954/REGENXBIO Inc. announced financial results for the quarter ended June 30, 2018, and recent operational highlights including updates to interim data from its ongoing clinical trials. Financial Results Cash, cash equivalents, and marketable securities were $306.3 million as of June
- Wills Eye Sponsors First Early Feasibility Study of a New Implantable Device for Blind Retinitis Pigmentosa Patientshttps://modernod.com/news/wills-eye-sponsors-first-us-early-feasibility-study-of-a-new-implantable-device-for-blind-retinitis-pigmentosa-patients/2479960/Wills Eye Hospital has been given FDA approval to begin an early feasibility study (EFS) to implant the RETINA IMPLANT Alpha AMS sub-retinal device in patients blind due to retinitis pigmentosa (RP). The Alpha AMS is manufactured by Retina Implant AG, Reutlingen,
- Guardion Health Sciences Receives Methods Patents to Standardize Vision Testinghttps://modernod.com/news/guardion-health-sciences-receives-methods-patents-to-standardize-vision-testing/2479965/On July 10 and July 17, 2018, Guardion Health Sciences was issued two patents by the United States Patent and Trademark Office, both entitled “Method and Apparatus for Visual Acuity Testing.” The first pat